Fitness Trends Contrast Media Contrast Agent Market | Page 3

Key players operating in the market:
In March, 2017, GE Healthcare has launched Clariscan, a gadolinium based contrast agent
designed to support effective visualization of abnormalities in the spine, brain and associated
tissues. Clariscan, also known to be a gold standard detection tool in MR imaging, allows
prompt detection of abnormalities by helping in improving contrast between pathological and
normal tissue.
The key players operating in the contrast media/contrast agent market include Lantheus Medical
Imaging, GE Healthcare, Bayer HealthCare, Bracco Imaging S.p.A, NanoPET Pharma GmbH,
Guerbet Group, CMC Contrast AB, Daiichi Sankyo, and Subhra Pharma Private Limited.
Inquire Here Before Purchase of Research Report @
https://www.coherentmarketinsights.com/insight/talk-to-analyst/1210
Contrast Media/ Contrast Agent Market Taxonomy:
Contrast Media/ Contrast Agent Market is segmented on the basis of media type, route of
administration, indication, end user and geography.
On the basis of media type, contrast media/contrast agent market is segmented into:
• Microbubble Contrast Media
• Iodinated Contrast Media
• Barium-Based Contrast Media
• Gadolinium-Based Contrast Media
On the basis of route of administration, contrast media/contrast agent market is segmented into:
• Oral
• Rectal
• Intravenous
• Urethral
On the basis of indication, contrast media/contrast agent market is segmented into:
• Neurological Disorders
• Nephrological Disorders
• Cardiovascular Disorders
• Gastrointestinal Disorders
• Oncology